National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 675728

History of Changes from the VAERS Wayback Machine

First Appeared on 5/14/2017

VAERS ID: 675728
VAERS Form:
Age:14.0
Gender:Female
Location:Foreign
Vaccinated:2009-05-12
Onset:2009-10-01
Submitted:2016-12-30
Entered:2016-12-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1941U / 2 UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Chronic fatigue syndrome, Postural orthostatic tachycardia syndrome

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: diclofenac
Current Illness: Endometriosis; Human papillomavirus immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': DK0095075131612DNK012920

Write-up: ADVERSE REACTION: Postural orthostatic tachycardia syndrome (POTS), chronic fatigue syndrome. THE COURSE REGARDING THE ADVERSE REACTION: Last GARDASIL administrated on 12-MAY-2009, during the autumn of 2009 increasing symptoms. OTHER VACCINES: No. Criteria for the diagnosing of POTS: 1) Heart rate increases greater than or equal to 30 bpm from supine to standing (10 min) in the absence of orthostatic hypotension (decrease in BP greater than 20/10 mmHg). 2) Symptoms worsen with standing and improved with recumbence. 3) Symptoms last greater than or equal to 6 months. 4) Absence of other overt cause of orthostatic symptoms or tachycardia (e.g., active bleeding, acute dehydration, medications). In addition Hospital /(where the patient is followed) uses further a criterion for patients between 12-19 years: Requires a pulse increase greater than 40 bpm to make the diagnosis, with the justification, that young people have a stronger physiological pulse response to standing up. They use this additional criterion to avoid false positive.


Changed on 9/14/2017

VAERS ID: 675728 Before After
VAERS Form:(blank) 1
Age:14.0
Gender:Female
Location:Foreign
Vaccinated:2009-05-12
Onset:2009-10-01
Submitted:2016-12-30
Entered:2016-12-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1941U / 2 3 UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Chronic fatigue syndrome, Postural orthostatic tachycardia syndrome

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: diclofenac
Current Illness: Endometriosis; Human papillomavirus immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': DK0095075131612DNK012920

Write-up: ADVERSE REACTION: Postural orthostatic tachycardia syndrome (POTS), chronic fatigue syndrome. THE COURSE REGARDING THE ADVERSE REACTION: Last GARDASIL administrated on 12-MAY-2009, during the autumn of 2009 increasing symptoms. OTHER VACCINES: No. Criteria for the diagnosing of POTS: 1) Heart rate increases greater than or equal to 30 bpm from supine to standing (10 min) in the absence of orthostatic hypotension (decrease in BP greater than 20/10 mmHg). 2) Symptoms worsen with standing and improved with recumbence. 3) Symptoms last greater than or equal to 6 months. 4) Absence of other overt cause of orthostatic symptoms or tachycardia (e.g., active bleeding, acute dehydration, medications). In addition Hospital /(where the patient is followed) uses further a criterion for patients between 12-19 years: Requires a pulse increase greater than 40 bpm to make the diagnosis, with the justification, that young people have a stronger physiological pulse response to standing up. They use this additional criterion to avoid false positive.


Changed on 2/14/2018

VAERS ID: 675728 Before After
VAERS Form:1
Age:14.0
Gender:Female
Location:Foreign
Vaccinated:2009-05-12
Onset:2009-10-01
Submitted:2016-12-30
Entered:2016-12-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1941U / 3 UN / UN

Administered by: Unknown      Purchased by: Unknown
Symptoms: Chronic fatigue syndrome, Postural orthostatic tachycardia syndrome

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: diclofenac
Current Illness: Endometriosis; Human papillomavirus immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': DK0095075131612DNK012920

Write-up: ADVERSE REACTION: Postural orthostatic tachycardia syndrome (POTS), chronic fatigue syndrome. THE COURSE REGARDING THE ADVERSE REACTION: Last GARDASIL administrated on 12-MAY-2009, during the autumn of 2009 increasing symptoms. OTHER VACCINES: No. Criteria for the diagnosing of POTS: 1) Heart rate increases greater than or equal to 30 bpm from supine to standing (10 min) in the absence of orthostatic hypotension (decrease in BP greater than 20/10 mmHg). 2) Symptoms worsen with standing and improved with recumbence. 3) Symptoms last greater than or equal to 6 months. 4) Absence of other overt cause of orthostatic symptoms or tachycardia (e.g., active bleeding, acute dehydration, medications). In addition Hospital /(where the patient is followed) uses further a criterion for patients between 12-19 years: Requires a pulse increase greater than 40 bpm to make the diagnosis, with the justification, that young people have a stronger physiological pulse response to standing up. They use this additional criterion to avoid false positive.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=675728&WAYBACKHISTORY=ON


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166